nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CHRM3—Amitriptyline—migraine	0.152	0.251	CbGbCtD
Cevimeline—CHRM1—Amitriptyline—migraine	0.132	0.218	CbGbCtD
Cevimeline—CYP2D6—Timolol—migraine	0.0575	0.0952	CbGbCtD
Cevimeline—CYP2D6—Propranolol—migraine	0.0512	0.0849	CbGbCtD
Cevimeline—CYP2D6—Amitriptyline—migraine	0.0443	0.0734	CbGbCtD
Cevimeline—CYP2D6—Verapamil—migraine	0.0352	0.0583	CbGbCtD
Cevimeline—CYP3A4—Propranolol—migraine	0.0326	0.054	CbGbCtD
Cevimeline—CYP3A4—Amitriptyline—migraine	0.0282	0.0467	CbGbCtD
Cevimeline—CYP3A4—Valproic Acid—migraine	0.0257	0.0426	CbGbCtD
Cevimeline—CYP3A4—Topiramate—migraine	0.0232	0.0384	CbGbCtD
Cevimeline—CYP3A4—Verapamil—migraine	0.0224	0.037	CbGbCtD
Cevimeline—CHRM1—Monoamine GPCRs—HTR1D—migraine	0.00147	0.0304	CbGpPWpGaD
Cevimeline—CHRM3—Monoamine GPCRs—HTR1D—migraine	0.00147	0.0304	CbGpPWpGaD
Cevimeline—CHRM1—Monoamine GPCRs—HTR2B—migraine	0.00137	0.0283	CbGpPWpGaD
Cevimeline—CHRM3—Monoamine GPCRs—HTR2B—migraine	0.00137	0.0282	CbGpPWpGaD
Cevimeline—CHRM1—Amine ligand-binding receptors—HTR1D—migraine	0.00124	0.0256	CbGpPWpGaD
Cevimeline—CHRM3—Amine ligand-binding receptors—HTR1D—migraine	0.00123	0.0255	CbGpPWpGaD
Cevimeline—CHRM1—Amine ligand-binding receptors—HTR2B—migraine	0.00115	0.0238	CbGpPWpGaD
Cevimeline—CHRM3—Amine ligand-binding receptors—HTR2B—migraine	0.00115	0.0237	CbGpPWpGaD
Cevimeline—CHRM1—Monoamine GPCRs—HTR1B—migraine	0.000893	0.0184	CbGpPWpGaD
Cevimeline—CHRM3—Monoamine GPCRs—HTR1B—migraine	0.00089	0.0184	CbGpPWpGaD
Cevimeline—CHRM1—Monoamine GPCRs—HTR1A—migraine	0.000859	0.0178	CbGpPWpGaD
Cevimeline—CHRM3—Monoamine GPCRs—HTR1A—migraine	0.000857	0.0177	CbGpPWpGaD
Cevimeline—CHRM1—Monoamine GPCRs—HTR2C—migraine	0.00083	0.0172	CbGpPWpGaD
Cevimeline—CHRM3—Monoamine GPCRs—HTR2C—migraine	0.000827	0.0171	CbGpPWpGaD
Cevimeline—CHRM3—Regulation of insulin secretion—CACNA1A—migraine	0.000778	0.0161	CbGpPWpGaD
Cevimeline—CHRM1—Amine ligand-binding receptors—HTR1B—migraine	0.000751	0.0155	CbGpPWpGaD
Cevimeline—CHRM3—Amine ligand-binding receptors—HTR1B—migraine	0.000748	0.0155	CbGpPWpGaD
Cevimeline—CHRM1—Monoamine GPCRs—HTR7—migraine	0.000727	0.015	CbGpPWpGaD
Cevimeline—CHRM3—Monoamine GPCRs—HTR7—migraine	0.000725	0.015	CbGpPWpGaD
Cevimeline—CHRM1—Amine ligand-binding receptors—HTR1A—migraine	0.000722	0.0149	CbGpPWpGaD
Cevimeline—CHRM3—Amine ligand-binding receptors—HTR1A—migraine	0.00072	0.0149	CbGpPWpGaD
Cevimeline—CHRM1—Amine ligand-binding receptors—HTR2C—migraine	0.000698	0.0144	CbGpPWpGaD
Cevimeline—CHRM3—Amine ligand-binding receptors—HTR2C—migraine	0.000696	0.0144	CbGpPWpGaD
Cevimeline—CHRM3—Integration of energy metabolism—CACNA1A—migraine	0.000612	0.0126	CbGpPWpGaD
Cevimeline—CHRM1—Amine ligand-binding receptors—HTR7—migraine	0.000611	0.0126	CbGpPWpGaD
Cevimeline—CHRM3—Amine ligand-binding receptors—HTR7—migraine	0.000609	0.0126	CbGpPWpGaD
Cevimeline—CHRM1—Monoamine GPCRs—HTR2A—migraine	0.000509	0.0105	CbGpPWpGaD
Cevimeline—CHRM3—Monoamine GPCRs—HTR2A—migraine	0.000508	0.0105	CbGpPWpGaD
Cevimeline—CHRM1—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.00046	0.00951	CbGpPWpGaD
Cevimeline—CHRM3—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000459	0.00948	CbGpPWpGaD
Cevimeline—CHRM1—Amine ligand-binding receptors—HTR2A—migraine	0.000428	0.00884	CbGpPWpGaD
Cevimeline—CHRM3—Amine ligand-binding receptors—HTR2A—migraine	0.000427	0.00882	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Other—EDNRA—migraine	0.000358	0.00739	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—HTR2B—migraine	0.000342	0.00707	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—HTR2B—migraine	0.000341	0.00704	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Other—HTR7—migraine	0.000322	0.00665	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000306	0.00632	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000305	0.0063	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000284	0.00588	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000283	0.00586	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—CACNA1A—migraine	0.000281	0.00581	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000264	0.00546	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000264	0.00545	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CALCRL—migraine	0.000255	0.00528	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—RAMP1—migraine	0.000255	0.00528	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CALCRL—migraine	0.000255	0.00526	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—RAMP1—migraine	0.000255	0.00526	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000244	0.00503	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000243	0.00502	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000227	0.00468	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000226	0.00467	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Other—HTR2A—migraine	0.000225	0.00466	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—TAC1—migraine	0.000211	0.00437	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—NPS—migraine	0.000211	0.00437	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—TAC1—migraine	0.000211	0.00435	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—NPS—migraine	0.000211	0.00435	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—HTR2C—migraine	0.000207	0.00428	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—HTR2C—migraine	0.000207	0.00427	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—EDNRA—migraine	0.000202	0.00417	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—EDNRA—migraine	0.000201	0.00415	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—NPS—migraine	0.000199	0.00412	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—SLC6A4—migraine	0.000196	0.00404	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000189	0.0039	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000189	0.0039	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000188	0.00389	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000188	0.00389	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—HTR1D—migraine	0.000186	0.00383	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000185	0.00383	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR1D—migraine	0.000185	0.00382	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000185	0.00382	CbGpPWpGaD
Cevimeline—Tinnitus—Gabapentin—migraine	0.000182	0.000522	CcSEcCtD
Cevimeline—Cardiac disorder—Gabapentin—migraine	0.000181	0.00052	CcSEcCtD
Cevimeline—Palpitations—Valproic Acid—migraine	0.000181	0.00052	CcSEcCtD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.00018	0.00373	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.00018	0.00371	CbGpPWpGaD
Cevimeline—Neuropathy peripheral—Topiramate—migraine	0.000179	0.000514	CcSEcCtD
Cevimeline—Cough—Valproic Acid—migraine	0.000179	0.000513	CcSEcCtD
Cevimeline—Dysgeusia—Timolol—migraine	0.000179	0.000513	CcSEcCtD
Cevimeline—Stomatitis—Topiramate—migraine	0.000178	0.000512	CcSEcCtD
Cevimeline—Urinary tract infection—Topiramate—migraine	0.000178	0.00051	CcSEcCtD
Cevimeline—Conjunctivitis—Topiramate—migraine	0.000178	0.00051	CcSEcCtD
Cevimeline—Hypertension—Valproic Acid—migraine	0.000177	0.000508	CcSEcCtD
Cevimeline—Diarrhoea—Propranolol—migraine	0.000175	0.000503	CcSEcCtD
Cevimeline—Chills—Gabapentin—migraine	0.000175	0.000503	CcSEcCtD
Cevimeline—Chest pain—Valproic Acid—migraine	0.000174	0.000501	CcSEcCtD
Cevimeline—Myalgia—Valproic Acid—migraine	0.000174	0.000501	CcSEcCtD
Cevimeline—Arthralgia—Valproic Acid—migraine	0.000174	0.000501	CcSEcCtD
Cevimeline—Haematuria—Topiramate—migraine	0.000174	0.0005	CcSEcCtD
Cevimeline—Anxiety—Valproic Acid—migraine	0.000174	0.000499	CcSEcCtD
Cevimeline—Hypersensitivity—Verapamil—migraine	0.000174	0.000499	CcSEcCtD
Cevimeline—CHRM1—GPCR ligand binding—HTR2B—migraine	0.000173	0.00356	CbGpPWpGaD
Cevimeline—Epistaxis—Topiramate—migraine	0.000172	0.000495	CcSEcCtD
Cevimeline—Alopecia—Gabapentin—migraine	0.000172	0.000495	CcSEcCtD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000172	0.00356	CbGpPWpGaD
Cevimeline—Discomfort—Valproic Acid—migraine	0.000172	0.000495	CcSEcCtD
Cevimeline—CHRM3—GPCR ligand binding—HTR2B—migraine	0.000172	0.00355	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000172	0.00355	CbGpPWpGaD
Cevimeline—Sinusitis—Topiramate—migraine	0.000171	0.000492	CcSEcCtD
Cevimeline—CHRM1—Circadian rythm related genes—HTR7—migraine	0.000171	0.00354	CbGpPWpGaD
Cevimeline—Agranulocytosis—Topiramate—migraine	0.000171	0.00049	CcSEcCtD
Cevimeline—Malnutrition—Gabapentin—migraine	0.00017	0.000488	CcSEcCtD
Cevimeline—Dizziness—Propranolol—migraine	0.000169	0.000487	CcSEcCtD
Cevimeline—Asthenia—Verapamil—migraine	0.000169	0.000486	CcSEcCtD
Cevimeline—Confusional state—Valproic Acid—migraine	0.000169	0.000484	CcSEcCtD
Cevimeline—Flatulence—Gabapentin—migraine	0.000167	0.00048	CcSEcCtD
Cevimeline—Oedema—Valproic Acid—migraine	0.000167	0.00048	CcSEcCtD
Cevimeline—Pruritus—Verapamil—migraine	0.000167	0.000479	CcSEcCtD
Cevimeline—Dysgeusia—Gabapentin—migraine	0.000166	0.000477	CcSEcCtD
Cevimeline—Infection—Valproic Acid—migraine	0.000166	0.000477	CcSEcCtD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000166	0.00343	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000165	0.00342	CbGpPWpGaD
Cevimeline—Haemoglobin—Topiramate—migraine	0.000165	0.000474	CcSEcCtD
Cevimeline—Rhinitis—Topiramate—migraine	0.000165	0.000472	CcSEcCtD
Cevimeline—Back pain—Gabapentin—migraine	0.000164	0.000472	CcSEcCtD
Cevimeline—Haemorrhage—Topiramate—migraine	0.000164	0.000471	CcSEcCtD
Cevimeline—Nervous system disorder—Valproic Acid—migraine	0.000164	0.000471	CcSEcCtD
Cevimeline—Vertigo—Timolol—migraine	0.000164	0.00047	CcSEcCtD
Cevimeline—Thrombocytopenia—Valproic Acid—migraine	0.000164	0.00047	CcSEcCtD
Cevimeline—Syncope—Timolol—migraine	0.000163	0.000469	CcSEcCtD
Cevimeline—Hallucination—Topiramate—migraine	0.000163	0.000469	CcSEcCtD
Cevimeline—Hypoaesthesia—Topiramate—migraine	0.000163	0.000469	CcSEcCtD
Cevimeline—Muscle spasms—Gabapentin—migraine	0.000163	0.000469	CcSEcCtD
Cevimeline—Tachycardia—Valproic Acid—migraine	0.000163	0.000468	CcSEcCtD
Cevimeline—Vomiting—Propranolol—migraine	0.000163	0.000468	CcSEcCtD
Cevimeline—Pharyngitis—Topiramate—migraine	0.000163	0.000468	CcSEcCtD
Cevimeline—Skin disorder—Valproic Acid—migraine	0.000162	0.000466	CcSEcCtD
Cevimeline—Oedema peripheral—Topiramate—migraine	0.000162	0.000464	CcSEcCtD
Cevimeline—Hyperhidrosis—Valproic Acid—migraine	0.000162	0.000464	CcSEcCtD
Cevimeline—Rash—Propranolol—migraine	0.000162	0.000464	CcSEcCtD
Cevimeline—Dermatitis—Propranolol—migraine	0.000161	0.000464	CcSEcCtD
Cevimeline—Diarrhoea—Verapamil—migraine	0.000161	0.000463	CcSEcCtD
Cevimeline—Palpitations—Timolol—migraine	0.000161	0.000463	CcSEcCtD
Cevimeline—Urethral disorder—Topiramate—migraine	0.000161	0.000462	CcSEcCtD
Cevimeline—Loss of consciousness—Timolol—migraine	0.00016	0.00046	CcSEcCtD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00016	0.00331	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00016	0.0033	CbGpPWpGaD
Cevimeline—Anorexia—Valproic Acid—migraine	0.000159	0.000458	CcSEcCtD
Cevimeline—Cough—Timolol—migraine	0.000159	0.000457	CcSEcCtD
Cevimeline—Tremor—Gabapentin—migraine	0.000159	0.000457	CcSEcCtD
Cevimeline—Visual impairment—Topiramate—migraine	0.000158	0.000454	CcSEcCtD
Cevimeline—Ill-defined disorder—Gabapentin—migraine	0.000158	0.000452	CcSEcCtD
Cevimeline—Hypertension—Timolol—migraine	0.000157	0.000452	CcSEcCtD
Cevimeline—Anaemia—Gabapentin—migraine	0.000157	0.000451	CcSEcCtD
Cevimeline—Hypotension—Valproic Acid—migraine	0.000156	0.000448	CcSEcCtD
Cevimeline—Agitation—Gabapentin—migraine	0.000156	0.000448	CcSEcCtD
Cevimeline—Dizziness—Verapamil—migraine	0.000156	0.000448	CcSEcCtD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000156	0.00322	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000155	0.00321	CbGpPWpGaD
Cevimeline—Chest pain—Timolol—migraine	0.000155	0.000446	CcSEcCtD
Cevimeline—Arthralgia—Timolol—migraine	0.000155	0.000446	CcSEcCtD
Cevimeline—Myalgia—Timolol—migraine	0.000155	0.000446	CcSEcCtD
Cevimeline—Anxiety—Timolol—migraine	0.000155	0.000444	CcSEcCtD
Cevimeline—Discomfort—Timolol—migraine	0.000153	0.00044	CcSEcCtD
Cevimeline—Eye disorder—Topiramate—migraine	0.000153	0.00044	CcSEcCtD
Cevimeline—Malaise—Gabapentin—migraine	0.000153	0.00044	CcSEcCtD
Cevimeline—Tinnitus—Topiramate—migraine	0.000153	0.000439	CcSEcCtD
Cevimeline—Vertigo—Gabapentin—migraine	0.000153	0.000438	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Valproic Acid—migraine	0.000152	0.000437	CcSEcCtD
Cevimeline—Cardiac disorder—Topiramate—migraine	0.000152	0.000437	CcSEcCtD
Cevimeline—Flushing—Topiramate—migraine	0.000152	0.000437	CcSEcCtD
Cevimeline—Syncope—Gabapentin—migraine	0.000152	0.000437	CcSEcCtD
Cevimeline—Nausea—Propranolol—migraine	0.000152	0.000437	CcSEcCtD
Cevimeline—Leukopenia—Gabapentin—migraine	0.000152	0.000436	CcSEcCtD
Cevimeline—Insomnia—Valproic Acid—migraine	0.000151	0.000434	CcSEcCtD
Cevimeline—Paraesthesia—Valproic Acid—migraine	0.00015	0.000431	CcSEcCtD
Cevimeline—Palpitations—Gabapentin—migraine	0.00015	0.000431	CcSEcCtD
Cevimeline—Confusional state—Timolol—migraine	0.00015	0.000431	CcSEcCtD
Cevimeline—Vomiting—Verapamil—migraine	0.00015	0.00043	CcSEcCtD
Cevimeline—Loss of consciousness—Gabapentin—migraine	0.000149	0.000428	CcSEcCtD
Cevimeline—Dyspnoea—Valproic Acid—migraine	0.000149	0.000428	CcSEcCtD
Cevimeline—Angiopathy—Topiramate—migraine	0.000149	0.000427	CcSEcCtD
Cevimeline—Oedema—Timolol—migraine	0.000149	0.000427	CcSEcCtD
Cevimeline—Rash—Verapamil—migraine	0.000149	0.000427	CcSEcCtD
Cevimeline—Somnolence—Valproic Acid—migraine	0.000149	0.000427	CcSEcCtD
Cevimeline—Dermatitis—Verapamil—migraine	0.000149	0.000426	CcSEcCtD
Cevimeline—Cough—Gabapentin—migraine	0.000148	0.000425	CcSEcCtD
Cevimeline—Infection—Timolol—migraine	0.000148	0.000424	CcSEcCtD
Cevimeline—Headache—Verapamil—migraine	0.000148	0.000424	CcSEcCtD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000148	0.00305	CbGpPWpGaD
Cevimeline—Chills—Topiramate—migraine	0.000147	0.000423	CcSEcCtD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000147	0.00304	CbGpPWpGaD
Cevimeline—Dyspepsia—Valproic Acid—migraine	0.000147	0.000422	CcSEcCtD
Cevimeline—Convulsion—Gabapentin—migraine	0.000147	0.000422	CcSEcCtD
Cevimeline—Hypertension—Gabapentin—migraine	0.000147	0.000421	CcSEcCtD
Cevimeline—Shock—Timolol—migraine	0.000146	0.00042	CcSEcCtD
Cevimeline—Nervous system disorder—Timolol—migraine	0.000146	0.000419	CcSEcCtD
Cevimeline—Decreased appetite—Valproic Acid—migraine	0.000145	0.000417	CcSEcCtD
Cevimeline—Alopecia—Topiramate—migraine	0.000145	0.000416	CcSEcCtD
Cevimeline—Myalgia—Gabapentin—migraine	0.000145	0.000415	CcSEcCtD
Cevimeline—Arthralgia—Gabapentin—migraine	0.000145	0.000415	CcSEcCtD
Cevimeline—Chest pain—Gabapentin—migraine	0.000145	0.000415	CcSEcCtD
Cevimeline—Skin disorder—Timolol—migraine	0.000145	0.000415	CcSEcCtD
Cevimeline—CHRM1—GPCR downstream signaling—CALCRL—migraine	0.000144	0.00298	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—RAMP1—migraine	0.000144	0.00298	CbGpPWpGaD
Cevimeline—Fatigue—Valproic Acid—migraine	0.000144	0.000414	CcSEcCtD
Cevimeline—Anxiety—Gabapentin—migraine	0.000144	0.000414	CcSEcCtD
Cevimeline—CHRM3—GPCR downstream signaling—CALCRL—migraine	0.000144	0.00297	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—RAMP1—migraine	0.000144	0.00297	CbGpPWpGaD
Cevimeline—Hyperhidrosis—Timolol—migraine	0.000144	0.000413	CcSEcCtD
Cevimeline—Pain—Valproic Acid—migraine	0.000143	0.00041	CcSEcCtD
Cevimeline—Constipation—Valproic Acid—migraine	0.000143	0.00041	CcSEcCtD
Cevimeline—Malnutrition—Topiramate—migraine	0.000143	0.00041	CcSEcCtD
Cevimeline—Discomfort—Gabapentin—migraine	0.000143	0.00041	CcSEcCtD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000142	0.00294	CbGpPWpGaD
Cevimeline—Anorexia—Timolol—migraine	0.000142	0.000407	CcSEcCtD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000142	0.00293	CbGpPWpGaD
Cevimeline—Flatulence—Topiramate—migraine	0.000141	0.000404	CcSEcCtD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.00014	0.0029	CbGpPWpGaD
Cevimeline—Nausea—Verapamil—migraine	0.00014	0.000402	CcSEcCtD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00014	0.00289	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00014	0.00289	CbGpPWpGaD
Cevimeline—Dysgeusia—Topiramate—migraine	0.00014	0.000402	CcSEcCtD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.00014	0.00289	CbGpPWpGaD
Cevimeline—Confusional state—Gabapentin—migraine	0.00014	0.000401	CcSEcCtD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00014	0.00288	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00014	0.00288	CbGpPWpGaD
Cevimeline—Hypotension—Timolol—migraine	0.000139	0.000399	CcSEcCtD
Cevimeline—Oedema—Gabapentin—migraine	0.000139	0.000398	CcSEcCtD
Cevimeline—Back pain—Topiramate—migraine	0.000138	0.000397	CcSEcCtD
Cevimeline—Feeling abnormal—Valproic Acid—migraine	0.000138	0.000396	CcSEcCtD
Cevimeline—Infection—Gabapentin—migraine	0.000138	0.000395	CcSEcCtD
Cevimeline—Muscle spasms—Topiramate—migraine	0.000137	0.000394	CcSEcCtD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000137	0.00284	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000137	0.00283	CbGpPWpGaD
Cevimeline—Gastrointestinal pain—Valproic Acid—migraine	0.000137	0.000392	CcSEcCtD
Cevimeline—Shock—Gabapentin—migraine	0.000136	0.000391	CcSEcCtD
Cevimeline—Nervous system disorder—Gabapentin—migraine	0.000136	0.00039	CcSEcCtD
Cevimeline—Thrombocytopenia—Gabapentin—migraine	0.000136	0.00039	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Timolol—migraine	0.000136	0.000389	CcSEcCtD
Cevimeline—Tachycardia—Gabapentin—migraine	0.000135	0.000388	CcSEcCtD
Cevimeline—Skin disorder—Gabapentin—migraine	0.000135	0.000386	CcSEcCtD
Cevimeline—Insomnia—Timolol—migraine	0.000135	0.000386	CcSEcCtD
Cevimeline—Hyperhidrosis—Gabapentin—migraine	0.000134	0.000385	CcSEcCtD
Cevimeline—Tremor—Topiramate—migraine	0.000134	0.000384	CcSEcCtD
Cevimeline—Paraesthesia—Timolol—migraine	0.000134	0.000384	CcSEcCtD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000134	0.00276	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000133	0.00275	CbGpPWpGaD
Cevimeline—Urticaria—Valproic Acid—migraine	0.000133	0.000381	CcSEcCtD
Cevimeline—Dyspnoea—Timolol—migraine	0.000133	0.000381	CcSEcCtD
Cevimeline—Ill-defined disorder—Topiramate—migraine	0.000133	0.000381	CcSEcCtD
Cevimeline—Somnolence—Timolol—migraine	0.000132	0.00038	CcSEcCtD
Cevimeline—Abdominal pain—Valproic Acid—migraine	0.000132	0.000379	CcSEcCtD
Cevimeline—Body temperature increased—Valproic Acid—migraine	0.000132	0.000379	CcSEcCtD
Cevimeline—Anorexia—Gabapentin—migraine	0.000132	0.000379	CcSEcCtD
Cevimeline—Anaemia—Topiramate—migraine	0.000132	0.000379	CcSEcCtD
Cevimeline—Agitation—Topiramate—migraine	0.000131	0.000377	CcSEcCtD
Cevimeline—CHRM1—Signaling by GPCR—CALCRL—migraine	0.000131	0.00271	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—RAMP1—migraine	0.000131	0.00271	CbGpPWpGaD
Cevimeline—Dyspepsia—Timolol—migraine	0.000131	0.000376	CcSEcCtD
Cevimeline—CHRM3—Signaling by GPCR—RAMP1—migraine	0.000131	0.0027	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CALCRL—migraine	0.000131	0.0027	CbGpPWpGaD
Cevimeline—Hypotension—Gabapentin—migraine	0.000129	0.000372	CcSEcCtD
Cevimeline—Decreased appetite—Timolol—migraine	0.000129	0.000371	CcSEcCtD
Cevimeline—Malaise—Topiramate—migraine	0.000129	0.00037	CcSEcCtD
Cevimeline—Vertigo—Topiramate—migraine	0.000128	0.000369	CcSEcCtD
Cevimeline—Fatigue—Timolol—migraine	0.000128	0.000368	CcSEcCtD
Cevimeline—Syncope—Topiramate—migraine	0.000128	0.000368	CcSEcCtD
Cevimeline—Leukopenia—Topiramate—migraine	0.000128	0.000367	CcSEcCtD
Cevimeline—Pain—Timolol—migraine	0.000127	0.000365	CcSEcCtD
Cevimeline—CHRM1—G alpha (q) signalling events—HTR2A—migraine	0.000127	0.00263	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—HTR2A—migraine	0.000127	0.00262	CbGpPWpGaD
Cevimeline—Musculoskeletal discomfort—Gabapentin—migraine	0.000126	0.000363	CcSEcCtD
Cevimeline—Palpitations—Topiramate—migraine	0.000126	0.000362	CcSEcCtD
Cevimeline—Loss of consciousness—Topiramate—migraine	0.000126	0.00036	CcSEcCtD
Cevimeline—Insomnia—Gabapentin—migraine	0.000125	0.00036	CcSEcCtD
Cevimeline—Cough—Topiramate—migraine	0.000125	0.000358	CcSEcCtD
Cevimeline—Paraesthesia—Gabapentin—migraine	0.000124	0.000357	CcSEcCtD
Cevimeline—Convulsion—Topiramate—migraine	0.000124	0.000355	CcSEcCtD
Cevimeline—Dyspnoea—Gabapentin—migraine	0.000124	0.000355	CcSEcCtD
Cevimeline—Hypertension—Topiramate—migraine	0.000123	0.000354	CcSEcCtD
Cevimeline—Somnolence—Gabapentin—migraine	0.000123	0.000354	CcSEcCtD
Cevimeline—Hypersensitivity—Valproic Acid—migraine	0.000123	0.000354	CcSEcCtD
Cevimeline—Feeling abnormal—Timolol—migraine	0.000123	0.000352	CcSEcCtD
Cevimeline—Dyspepsia—Gabapentin—migraine	0.000122	0.00035	CcSEcCtD
Cevimeline—Gastrointestinal pain—Timolol—migraine	0.000122	0.000349	CcSEcCtD
Cevimeline—Arthralgia—Topiramate—migraine	0.000122	0.000349	CcSEcCtD
Cevimeline—Chest pain—Topiramate—migraine	0.000122	0.000349	CcSEcCtD
Cevimeline—Myalgia—Topiramate—migraine	0.000122	0.000349	CcSEcCtD
Cevimeline—Anxiety—Topiramate—migraine	0.000121	0.000348	CcSEcCtD
Cevimeline—Decreased appetite—Gabapentin—migraine	0.00012	0.000346	CcSEcCtD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.00012	0.00248	CbGpPWpGaD
Cevimeline—Discomfort—Topiramate—migraine	0.00012	0.000345	CcSEcCtD
Cevimeline—Asthenia—Valproic Acid—migraine	0.00012	0.000344	CcSEcCtD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.00012	0.00248	CbGpPWpGaD
Cevimeline—Fatigue—Gabapentin—migraine	0.000119	0.000343	CcSEcCtD
Cevimeline—Pain—Gabapentin—migraine	0.000118	0.00034	CcSEcCtD
Cevimeline—Constipation—Gabapentin—migraine	0.000118	0.00034	CcSEcCtD
Cevimeline—Pruritus—Valproic Acid—migraine	0.000118	0.00034	CcSEcCtD
Cevimeline—Urticaria—Timolol—migraine	0.000118	0.000339	CcSEcCtD
Cevimeline—Abdominal pain—Timolol—migraine	0.000118	0.000338	CcSEcCtD
Cevimeline—Body temperature increased—Timolol—migraine	0.000118	0.000338	CcSEcCtD
Cevimeline—Confusional state—Topiramate—migraine	0.000118	0.000338	CcSEcCtD
Cevimeline—Oedema—Topiramate—migraine	0.000117	0.000335	CcSEcCtD
Cevimeline—Infection—Topiramate—migraine	0.000116	0.000333	CcSEcCtD
Cevimeline—Shock—Topiramate—migraine	0.000115	0.000329	CcSEcCtD
Cevimeline—Diarrhoea—Valproic Acid—migraine	0.000114	0.000328	CcSEcCtD
Cevimeline—Nervous system disorder—Topiramate—migraine	0.000114	0.000328	CcSEcCtD
Cevimeline—Feeling abnormal—Gabapentin—migraine	0.000114	0.000328	CcSEcCtD
Cevimeline—Thrombocytopenia—Topiramate—migraine	0.000114	0.000328	CcSEcCtD
Cevimeline—Tachycardia—Topiramate—migraine	0.000114	0.000327	CcSEcCtD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000114	0.00235	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000113	0.00234	CbGpPWpGaD
Cevimeline—Gastrointestinal pain—Gabapentin—migraine	0.000113	0.000325	CcSEcCtD
Cevimeline—Skin disorder—Topiramate—migraine	0.000113	0.000325	CcSEcCtD
Cevimeline—Hyperhidrosis—Topiramate—migraine	0.000113	0.000324	CcSEcCtD
Cevimeline—CHRM1—GPCR ligand binding—HTR1B—migraine	0.000112	0.00232	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR1B—migraine	0.000112	0.00232	CbGpPWpGaD
Cevimeline—Anorexia—Topiramate—migraine	0.000111	0.000319	CcSEcCtD
Cevimeline—Dizziness—Valproic Acid—migraine	0.000111	0.000317	CcSEcCtD
Cevimeline—Urticaria—Gabapentin—migraine	0.00011	0.000316	CcSEcCtD
Cevimeline—Hypersensitivity—Timolol—migraine	0.00011	0.000315	CcSEcCtD
Cevimeline—Abdominal pain—Gabapentin—migraine	0.00011	0.000315	CcSEcCtD
Cevimeline—Body temperature increased—Gabapentin—migraine	0.00011	0.000315	CcSEcCtD
Cevimeline—Hypotension—Topiramate—migraine	0.000109	0.000313	CcSEcCtD
Cevimeline—CHRM1—GPCR ligand binding—HTR1A—migraine	0.000108	0.00224	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR1A—migraine	0.000108	0.00223	CbGpPWpGaD
Cevimeline—Asthenia—Timolol—migraine	0.000107	0.000307	CcSEcCtD
Cevimeline—CHRM1—GPCR ligand binding—TAC1—migraine	0.000107	0.0022	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—NPS—migraine	0.000107	0.0022	CbGpPWpGaD
Cevimeline—Vomiting—Valproic Acid—migraine	0.000106	0.000305	CcSEcCtD
Cevimeline—CHRM3—GPCR ligand binding—TAC1—migraine	0.000106	0.00219	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—NPS—migraine	0.000106	0.00219	CbGpPWpGaD
Cevimeline—Musculoskeletal discomfort—Topiramate—migraine	0.000106	0.000305	CcSEcCtD
Cevimeline—Insomnia—Topiramate—migraine	0.000105	0.000303	CcSEcCtD
Cevimeline—Rash—Valproic Acid—migraine	0.000105	0.000303	CcSEcCtD
Cevimeline—Dermatitis—Valproic Acid—migraine	0.000105	0.000302	CcSEcCtD
Cevimeline—Pruritus—Timolol—migraine	0.000105	0.000302	CcSEcCtD
Cevimeline—CHRM1—GPCR downstream signaling—HTR1D—migraine	0.000105	0.00217	CbGpPWpGaD
Cevimeline—Headache—Valproic Acid—migraine	0.000105	0.000301	CcSEcCtD
Cevimeline—Paraesthesia—Topiramate—migraine	0.000105	0.000301	CcSEcCtD
Cevimeline—CHRM3—GPCR downstream signaling—HTR1D—migraine	0.000105	0.00216	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—HTR2C—migraine	0.000105	0.00216	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR2C—migraine	0.000104	0.00215	CbGpPWpGaD
Cevimeline—Dyspnoea—Topiramate—migraine	0.000104	0.000298	CcSEcCtD
Cevimeline—Somnolence—Topiramate—migraine	0.000104	0.000298	CcSEcCtD
Cevimeline—Dyspepsia—Topiramate—migraine	0.000103	0.000295	CcSEcCtD
Cevimeline—Hypersensitivity—Gabapentin—migraine	0.000102	0.000293	CcSEcCtD
Cevimeline—Diarrhoea—Timolol—migraine	0.000102	0.000292	CcSEcCtD
Cevimeline—CHRM1—GPCR ligand binding—EDNRA—migraine	0.000102	0.0021	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—EDNRA—migraine	0.000101	0.00209	CbGpPWpGaD
Cevimeline—Decreased appetite—Topiramate—migraine	0.000101	0.000291	CcSEcCtD
Cevimeline—Fatigue—Topiramate—migraine	0.000101	0.000289	CcSEcCtD
Cevimeline—Constipation—Topiramate—migraine	9.97e-05	0.000286	CcSEcCtD
Cevimeline—Pain—Topiramate—migraine	9.97e-05	0.000286	CcSEcCtD
Cevimeline—Asthenia—Gabapentin—migraine	9.94e-05	0.000285	CcSEcCtD
Cevimeline—Nausea—Valproic Acid—migraine	9.93e-05	0.000285	CcSEcCtD
Cevimeline—Dizziness—Timolol—migraine	9.84e-05	0.000283	CcSEcCtD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	9.83e-05	0.00203	CbGpPWpGaD
Cevimeline—Pruritus—Gabapentin—migraine	9.8e-05	0.000282	CcSEcCtD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	9.8e-05	0.00202	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CALCA—migraine	9.79e-05	0.00202	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CALCA—migraine	9.76e-05	0.00202	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR2B—migraine	9.75e-05	0.00201	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR2B—migraine	9.72e-05	0.00201	CbGpPWpGaD
Cevimeline—Feeling abnormal—Topiramate—migraine	9.61e-05	0.000276	CcSEcCtD
Cevimeline—Gastrointestinal pain—Topiramate—migraine	9.53e-05	0.000274	CcSEcCtD
Cevimeline—CHRM1—Signaling by GPCR—HTR1D—migraine	9.52e-05	0.00197	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR1D—migraine	9.49e-05	0.00196	CbGpPWpGaD
Cevimeline—Diarrhoea—Gabapentin—migraine	9.48e-05	0.000272	CcSEcCtD
Cevimeline—Vomiting—Timolol—migraine	9.46e-05	0.000272	CcSEcCtD
Cevimeline—Rash—Timolol—migraine	9.38e-05	0.000269	CcSEcCtD
Cevimeline—Dermatitis—Timolol—migraine	9.37e-05	0.000269	CcSEcCtD
Cevimeline—Headache—Timolol—migraine	9.32e-05	0.000268	CcSEcCtD
Cevimeline—FMO1—Metabolism—MTHFR—migraine	9.3e-05	0.00192	CbGpPWpGaD
Cevimeline—Urticaria—Topiramate—migraine	9.26e-05	0.000266	CcSEcCtD
Cevimeline—Abdominal pain—Topiramate—migraine	9.22e-05	0.000265	CcSEcCtD
Cevimeline—Body temperature increased—Topiramate—migraine	9.22e-05	0.000265	CcSEcCtD
Cevimeline—Dizziness—Gabapentin—migraine	9.16e-05	0.000263	CcSEcCtD
Cevimeline—CHRM1—GPCR ligand binding—HTR7—migraine	9.15e-05	0.00189	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR7—migraine	9.12e-05	0.00189	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR2B—migraine	8.85e-05	0.00183	CbGpPWpGaD
Cevimeline—Nausea—Timolol—migraine	8.84e-05	0.000254	CcSEcCtD
Cevimeline—CHRM3—Signaling by GPCR—HTR2B—migraine	8.82e-05	0.00182	CbGpPWpGaD
Cevimeline—Vomiting—Gabapentin—migraine	8.81e-05	0.000253	CcSEcCtD
Cevimeline—Rash—Gabapentin—migraine	8.74e-05	0.000251	CcSEcCtD
Cevimeline—Dermatitis—Gabapentin—migraine	8.73e-05	0.000251	CcSEcCtD
Cevimeline—Headache—Gabapentin—migraine	8.68e-05	0.000249	CcSEcCtD
Cevimeline—Hypersensitivity—Topiramate—migraine	8.59e-05	0.000247	CcSEcCtD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	8.42e-05	0.00174	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	8.39e-05	0.00173	CbGpPWpGaD
Cevimeline—Asthenia—Topiramate—migraine	8.36e-05	0.00024	CcSEcCtD
Cevimeline—Pruritus—Topiramate—migraine	8.25e-05	0.000237	CcSEcCtD
Cevimeline—Nausea—Gabapentin—migraine	8.23e-05	0.000236	CcSEcCtD
Cevimeline—Diarrhoea—Topiramate—migraine	7.98e-05	0.000229	CcSEcCtD
Cevimeline—CHRM1—Signaling Pathways—CALCRL—migraine	7.74e-05	0.0016	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RAMP1—migraine	7.74e-05	0.0016	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RAMP1—migraine	7.72e-05	0.00159	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CALCRL—migraine	7.72e-05	0.00159	CbGpPWpGaD
Cevimeline—Dizziness—Topiramate—migraine	7.71e-05	0.000221	CcSEcCtD
Cevimeline—Vomiting—Topiramate—migraine	7.41e-05	0.000213	CcSEcCtD
Cevimeline—Rash—Topiramate—migraine	7.35e-05	0.000211	CcSEcCtD
Cevimeline—Dermatitis—Topiramate—migraine	7.34e-05	0.000211	CcSEcCtD
Cevimeline—Headache—Topiramate—migraine	7.3e-05	0.00021	CcSEcCtD
Cevimeline—CHRM3—Metabolism—CACNA1A—migraine	6.99e-05	0.00145	CbGpPWpGaD
Cevimeline—Nausea—Topiramate—migraine	6.92e-05	0.000199	CcSEcCtD
Cevimeline—CHRM1—GPCR ligand binding—HTR2A—migraine	6.41e-05	0.00132	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR2A—migraine	6.39e-05	0.00132	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR1B—migraine	6.35e-05	0.00131	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR1B—migraine	6.33e-05	0.00131	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR1A—migraine	6.12e-05	0.00126	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR1A—migraine	6.1e-05	0.00126	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—TAC1—migraine	6.02e-05	0.00124	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—NPS—migraine	6.02e-05	0.00124	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—TAC1—migraine	6e-05	0.00124	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—NPS—migraine	6e-05	0.00124	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR2C—migraine	5.91e-05	0.00122	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR2C—migraine	5.89e-05	0.00122	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR1B—migraine	5.77e-05	0.00119	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR1B—migraine	5.75e-05	0.00119	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—EDNRA—migraine	5.75e-05	0.00119	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—EDNRA—migraine	5.73e-05	0.00118	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR1D—migraine	5.63e-05	0.00116	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR1D—migraine	5.61e-05	0.00116	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR1A—migraine	5.55e-05	0.00115	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR1A—migraine	5.54e-05	0.00114	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CALCA—migraine	5.53e-05	0.00114	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CALCA—migraine	5.51e-05	0.00114	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—NPS—migraine	5.47e-05	0.00113	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—TAC1—migraine	5.47e-05	0.00113	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—TAC1—migraine	5.45e-05	0.00113	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—NPS—migraine	5.45e-05	0.00113	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR2C—migraine	5.36e-05	0.00111	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR2C—migraine	5.35e-05	0.0011	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR2B—migraine	5.23e-05	0.00108	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—EDNRA—migraine	5.22e-05	0.00108	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR2B—migraine	5.21e-05	0.00108	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—EDNRA—migraine	5.2e-05	0.00107	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR7—migraine	5.17e-05	0.00107	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR7—migraine	5.16e-05	0.00107	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CALCA—migraine	5.02e-05	0.00104	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CALCA—migraine	5.01e-05	0.00103	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR7—migraine	4.7e-05	0.000971	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR7—migraine	4.68e-05	0.000967	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LRP1—migraine	4.6e-05	0.000951	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LRP1—migraine	4.59e-05	0.000948	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CACNA1A—migraine	4.18e-05	0.000864	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR2A—migraine	3.62e-05	0.000749	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR2A—migraine	3.61e-05	0.000746	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOTCH4—migraine	3.53e-05	0.00073	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOTCH4—migraine	3.52e-05	0.000728	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR1B—migraine	3.41e-05	0.000704	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR1B—migraine	3.4e-05	0.000702	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR2A—migraine	3.29e-05	0.00068	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR1A—migraine	3.28e-05	0.000678	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR2A—migraine	3.28e-05	0.000678	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR1A—migraine	3.27e-05	0.000676	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NPS—migraine	3.23e-05	0.000668	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PGR—migraine	3.23e-05	0.000668	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TAC1—migraine	3.23e-05	0.000668	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PGR—migraine	3.22e-05	0.000665	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NPS—migraine	3.22e-05	0.000665	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TAC1—migraine	3.22e-05	0.000665	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR2C—migraine	3.17e-05	0.000655	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR2C—migraine	3.16e-05	0.000653	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EDNRA—migraine	3.08e-05	0.000637	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EDNRA—migraine	3.07e-05	0.000635	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOTCH3—migraine	3e-05	0.000621	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOTCH3—migraine	2.99e-05	0.000619	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CALCA—migraine	2.97e-05	0.000613	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CALCA—migraine	2.96e-05	0.000611	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR7—migraine	2.78e-05	0.000573	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR7—migraine	2.77e-05	0.000572	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CACNA1A—migraine	2.73e-05	0.000565	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TGFBR2—migraine	2.39e-05	0.000494	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TGFBR2—migraine	2.38e-05	0.000492	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MTHFR—migraine	2.31e-05	0.000478	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR2A—migraine	1.94e-05	0.000402	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR2A—migraine	1.94e-05	0.0004	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ESR1—migraine	1.73e-05	0.000356	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ESR1—migraine	1.72e-05	0.000355	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MTHFR—migraine	1.38e-05	0.000286	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MTHFR—migraine	9.05e-06	0.000187	CbGpPWpGaD
